Citrus Sinensis ID: 007577


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------
MGSTSTISLYSHPKLSHRAQPVLSRSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAAARPEGGRRQRRVYRQSQSDNALTTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
ccccccccccccccccccccccccHHHcccccccccccccccccccccccHHHHHHHcccccccHHHHHHHHHHccccccccccHHHHHccccccHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHccccEEEcccccccHHHHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHcccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEEccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEEEcccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHccccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEEccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHccccccccEEEEccccccHHHHHHHHHHHHHcccccccEEEcccccccHHHHHHHHHHHHHcccccccEEEEcc
cccccEEEEcccccccccccHHHccccHcccccccccccccEEEcccccccEEEEEEccccccccHHHHHHHHHHHHcccccccHHHHEEccccccHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHcccccEEEEEcccccccHHHHHHHHHHHHHcccccEEEccccccHHHHHHHHHHHHHcccccEEEEEccccccHHHHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHccccccEEEEcccccccHHHHHHHHHHHHHcccccEEEccccccHHHHHHHHHHHHccccccccEEEcccccccHHHHHHHHHHHHHcccccEEEccccccHHHHHHHHHHHHccccccEEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHccccccEEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEEcccccccHHHHHHHHHHHHcccccEEEEEEcccccccHHHHHHHHHHHHccccHHHEEEEccc
mgststislyshpklshraqpvlsrsfcqardaplsfalpfsgtrrcfRLKRLVVKAaarpeggrrqrRVYRqsqsdnalttapvkQIASFVVPAGVFVSATFVLWKLVEKllmpkpsrpskptaegmnwsvgagtnllsgftgKLFRESKQTLNEFAKELRAFSsvdmsgrnfgdeGLFFLAESlgynqtaeevsfAANGITAAGIKAFDGVLQSNIALktlnlsgnpigdegVKCLCDILvdnagverlqlssVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTirslhlngnyggaLGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDignnsisakGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQnrtittidlggnnihskGASAIARVLkdnsvitsldlaynpigaDGAKALSEVLKFHGnintlklgwcqigaSGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
mgststislyshpklshrAQPVLSRSFCQARDAPLsfalpfsgtrrcfRLKRLvvkaaarpeggrrqrrvyrqsqsdnalttapvKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTIttidlggnnihSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
MGSTSTISLYSHPKLSHRAQPVLSRSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAAARPEGGrrqrrvyrqsqsDNALTTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHlngnyggalganalakglegnKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
************************RSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAA**********************TTAPVKQIASFVVPAGVFVSATFVLWKLVEKLL***************NWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYE**********
*****T**LYS*******************RDAPLSFALPFSGTRRCFRLKRLVVKAAA******************NALTTAPVKQIASFVVPAGVFVSATFVLWKLVEKL*****************WSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
********LYSHPKLSHRAQPVLSRSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAAA*********************TTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKP********EGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
***TSTISLYSHPKLSHRAQPVLSRSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAAARPEGGRRQRRVYRQSQSDNALTTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MGSTSTISLYSHPKLSHRAQPVLSRSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAAARPEGGRRQRRVYRQSQSDNALTTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query597 2.2.26 [Sep-21-2011]
Q7RTR21065 Protein NLRC3 OS=Homo sap yes no 0.716 0.401 0.360 1e-53
Q5DU561064 Protein NLRC3 OS=Mus musc yes no 0.705 0.395 0.340 3e-46
P29315456 Ribonuclease inhibitor OS yes no 0.648 0.848 0.264 2e-27
Q91VI7456 Ribonuclease inhibitor OS no no 0.604 0.791 0.274 3e-26
P10775456 Ribonuclease inhibitor OS no no 0.613 0.802 0.264 6e-26
Q647I91098 NACHT, LRR and PYD domain no no 0.576 0.313 0.281 1e-25
P13489461 Ribonuclease inhibitor OS no no 0.680 0.880 0.267 6e-24
Q9LE82535 RAN GTPase-activating pro no no 0.621 0.693 0.262 1e-23
Q8HZP9461 Ribonuclease inhibitor OS no no 0.680 0.880 0.267 2e-23
Q8BHB0953 Nucleotide-binding oligom no no 0.365 0.228 0.32 3e-23
>sp|Q7RTR2|NLRC3_HUMAN Protein NLRC3 OS=Homo sapiens GN=NLRC3 PE=2 SV=2 Back     alignment and function desciption
 Score =  211 bits (537), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 156/433 (36%), Positives = 232/433 (53%), Gaps = 5/433 (1%)

Query: 150  SKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESL-GYNQTAEEVSFAANGITAAGIK 208
            S+  L     +L     + +    F D  +  L   L G +   +++S A N I+  G K
Sbjct: 625  SQGVLQSLLPQLLYCRKLRLDTNQFQDPVMELLGSVLSGKDCRIQKISLAENQISNKGAK 684

Query: 209  AFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAE 268
            A    L  N +L +L+L GN IG +G K L D L  N  +  L L    +RD+GA+++AE
Sbjct: 685  ALARSLLVNRSLTSLDLRGNSIGPQGAKALADALKINRTLTSLSLQGNTVRDDGARSMAE 744

Query: 269  LLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEG 328
             L +N  L +L L  N I   G   +A+AL +N +++ L  + N  G  GA ALA+ L+ 
Sbjct: 745  ALASNRTLSMLHLQKNSIGPMGAQRMADALKQNRSLKELMFSSNSIGDGGAKALAEALKV 804

Query: 329  NKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKS 388
            N+ L  L L  NSI D G+ ALM  L + +  L+ L +  NSIS +GA  +A  +    +
Sbjct: 805  NQGLESLDLQSNSISDAGVAALMGALCTNQTLLS-LSLRENSISPEGAQAIAHALCANST 863

Query: 389  LLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSL 448
            L  ++L  N + D+GA  IA A+++NRT+T++ L  N I +  A A+ + L+ N  +TSL
Sbjct: 864  LKNLDLTANLLHDQGARAIAVAVRENRTLTSLHLQWNFIQAGAAQALGQALQLNRSLTSL 923

Query: 449  DLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRA 508
            DL  N IG DGA A++  LK +  +  L L    IGASGA+ + + L  N T+ ILDLR 
Sbjct: 924  DLQENAIGDDGACAVARALKVNTALTALYLQVASIGASGAQVLGEALAVNRTLEILDLRG 983

Query: 509  NGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANN 568
            N +   GAK LA + K VN +L  ++L  N +  DGA  IA AL  N    +  +NL  N
Sbjct: 984  NAIGVAGAKALANALK-VNSSLRRLNLQENSLGMDGAICIATALSGNHR--LQHINLQGN 1040

Query: 569  FLTKFGQSALTDA 581
             +   G   +++A
Sbjct: 1041 HIGDSGARMISEA 1053




May modulate T-cell activation. Decreases the transcription of genes that are normally up-regulated after T-cell stimulation. Delays degradation of NFKBIA/IKBA.
Homo sapiens (taxid: 9606)
>sp|Q5DU56|NLRC3_MOUSE Protein NLRC3 OS=Mus musculus GN=Nlrc3 PE=2 SV=2 Back     alignment and function description
>sp|P29315|RINI_RAT Ribonuclease inhibitor OS=Rattus norvegicus GN=Rnh1 PE=1 SV=2 Back     alignment and function description
>sp|Q91VI7|RINI_MOUSE Ribonuclease inhibitor OS=Mus musculus GN=Rnh1 PE=1 SV=1 Back     alignment and function description
>sp|P10775|RINI_PIG Ribonuclease inhibitor OS=Sus scrofa GN=RNH1 PE=1 SV=1 Back     alignment and function description
>sp|Q647I9|NALP5_BOVIN NACHT, LRR and PYD domains-containing protein 5 OS=Bos taurus GN=NLRP5 PE=2 SV=1 Back     alignment and function description
>sp|P13489|RINI_HUMAN Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 Back     alignment and function description
>sp|Q9LE82|RAGP1_ARATH RAN GTPase-activating protein 1 OS=Arabidopsis thaliana GN=RANGAP1 PE=1 SV=1 Back     alignment and function description
>sp|Q8HZP9|RINI_PANTR Ribonuclease inhibitor OS=Pan troglodytes GN=RNH1 PE=2 SV=3 Back     alignment and function description
>sp|Q8BHB0|NOD1_MOUSE Nucleotide-binding oligomerization domain-containing protein 1 OS=Mus musculus GN=Nod1 PE=2 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query597
296086512630 unnamed protein product [Vitis vinifera] 0.988 0.936 0.713 0.0
255558382607 leucine rich repeat-containing protein, 0.988 0.971 0.718 0.0
356501981606 PREDICTED: protein NLRC3-like [Glycine m 0.998 0.983 0.710 0.0
359473416684 PREDICTED: protein NLRC3-like [Vitis vin 0.968 0.845 0.733 0.0
357486129606 Nucleotide-binding oligomerization domai 0.993 0.978 0.707 0.0
297843864605 EMB2004 [Arabidopsis lyrata subsp. lyrat 0.993 0.980 0.711 0.0
18391166605 leucine-rich repeats-ribonuclease inhibi 0.993 0.980 0.711 0.0
356498020606 PREDICTED: protein NLRC3-like [Glycine m 0.998 0.983 0.700 0.0
258678027614 chloroplast envelope protein 1 [Nicotian 0.996 0.969 0.675 0.0
449452044602 PREDICTED: LOW QUALITY PROTEIN: protein 0.981 0.973 0.680 0.0
>gi|296086512|emb|CBI32101.3| unnamed protein product [Vitis vinifera] Back     alignment and taxonomy information
 Score =  874 bits (2257), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 450/631 (71%), Positives = 507/631 (80%), Gaps = 41/631 (6%)

Query: 3   STSTISLYSHP-------------------KLSHRAQPVLSRS---------FCQARDAP 34
           STS I LYSHP                   ++SHRA+P   RS         +C    A 
Sbjct: 5   STSAICLYSHPMVLSSSSSQSPNLTFCSDSQISHRARPRNLRSQVLGSSWWGYC----AL 60

Query: 35  LSFALPFSGTRRCFRLKRLVVKAAARPEGGRRQ----RRVYRQSQSDNALTTAPVKQIAS 90
           L  ++  S  R  +R + LV  AA+  +G  R+    RRV++QSQ    L+  PV++IAS
Sbjct: 61  LPTSVYVSSIRH-YRFRTLVTVAASTADGVPRRPVSGRRVFKQSQGQGPLSPVPVREIAS 119

Query: 91  FVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTA----EGMNWSVGAGTNLLSGFTGKL 146
           FVVPA +F + TFVLW+LVEK+L+PK SR S         G+ WS   GTNLL+G T K 
Sbjct: 120 FVVPASLFFAVTFVLWRLVEKILLPKSSRSSSLEKKSSSPGVKWSFAPGTNLLAGLTAKF 179

Query: 147 FRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAG 206
            RESKQ LNEFAKE+R+F SVDMSGRNFGDEGLFFLAESL YNQ AEEVSFAANGITAAG
Sbjct: 180 DRESKQKLNEFAKEIRSFGSVDMSGRNFGDEGLFFLAESLAYNQNAEEVSFAANGITAAG 239

Query: 207 IKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAI 266
           +KAFDGVLQSNI LKTL+LSGNPIGDEG KCLCDIL+DNAG+++LQL+S DL DEGAKAI
Sbjct: 240 LKAFDGVLQSNIVLKTLDLSGNPIGDEGAKCLCDILIDNAGIQKLQLNSADLGDEGAKAI 299

Query: 267 AELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGL 326
           AE+LK NS LR++ELNNNMIDYSGFTSL  ALLEN+TIR++HLNGNYGGALG  ALAKGL
Sbjct: 300 AEMLKKNSSLRIVELNNNMIDYSGFTSLGGALLENNTIRNIHLNGNYGGALGVAALAKGL 359

Query: 327 EGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNC 386
           E NKSLRELHLHGNSIGDEG+R LMSGLSS KGKL +LDIGNN IS++GAFHVAEYIK  
Sbjct: 360 EANKSLRELHLHGNSIGDEGVRVLMSGLSSHKGKLTLLDIGNNEISSRGAFHVAEYIKKA 419

Query: 387 KSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVIT 446
           KSLLW+NLYMNDIGDEGAEKIADALK+NR+I TIDLGGNNIH+KG S IA VLKDN+VIT
Sbjct: 420 KSLLWLNLYMNDIGDEGAEKIADALKENRSIATIDLGGNNIHAKGVSKIAGVLKDNTVIT 479

Query: 447 SLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDL 506
           +L+L YNPIG +GAKALSEVLKFHG I TLKLGWCQIGA GAEF+AD L+YN TIS LDL
Sbjct: 480 TLELGYNPIGPEGAKALSEVLKFHGKIKTLKLGWCQIGAKGAEFIADTLKYNTTISTLDL 539

Query: 507 RANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLA 566
           RANGLRDEGA CLA+S KVVNEAL S+DL FNEIRD+GAFAIAQALKANEDVAVTSLNLA
Sbjct: 540 RANGLRDEGAVCLARSMKVVNEALASLDLGFNEIRDEGAFAIAQALKANEDVAVTSLNLA 599

Query: 567 NNFLTKFGQSALTDAKDLVYEMSEKEVNIFF 597
           +NFLTKFGQSALTDA+D VYEMSEKEVNIFF
Sbjct: 600 SNFLTKFGQSALTDARDHVYEMSEKEVNIFF 630




Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255558382|ref|XP_002520218.1| leucine rich repeat-containing protein, putative [Ricinus communis] gi|223540710|gb|EEF42273.1| leucine rich repeat-containing protein, putative [Ricinus communis] Back     alignment and taxonomy information
>gi|356501981|ref|XP_003519801.1| PREDICTED: protein NLRC3-like [Glycine max] Back     alignment and taxonomy information
>gi|359473416|ref|XP_002266381.2| PREDICTED: protein NLRC3-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|357486129|ref|XP_003613352.1| Nucleotide-binding oligomerization domain-containing protein [Medicago truncatula] gi|355514687|gb|AES96310.1| Nucleotide-binding oligomerization domain-containing protein [Medicago truncatula] Back     alignment and taxonomy information
>gi|297843864|ref|XP_002889813.1| EMB2004 [Arabidopsis lyrata subsp. lyrata] gi|297335655|gb|EFH66072.1| EMB2004 [Arabidopsis lyrata subsp. lyrata] Back     alignment and taxonomy information
>gi|18391166|ref|NP_563871.1| leucine-rich repeats-ribonuclease inhibitor domain-containing protein [Arabidopsis thaliana] gi|15810395|gb|AAL07085.1| unknown protein [Arabidopsis thaliana] gi|20258921|gb|AAM14154.1| unknown protein [Arabidopsis thaliana] gi|332190466|gb|AEE28587.1| leucine-rich repeats-ribonuclease inhibitor domain-containing protein [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|356498020|ref|XP_003517853.1| PREDICTED: protein NLRC3-like [Glycine max] Back     alignment and taxonomy information
>gi|258678027|gb|ACV87735.1| chloroplast envelope protein 1 [Nicotiana benthamiana] Back     alignment and taxonomy information
>gi|449452044|ref|XP_004143770.1| PREDICTED: LOW QUALITY PROTEIN: protein NLRC3-like [Cucumis sativus] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query597
TAIR|locus:2194604605 emb2004 "embryo defective 2004 0.993 0.980 0.668 1.4e-204
UNIPROTKB|Q7RTR21065 NLRC3 "Protein NLRC3" [Homo sa 0.716 0.401 0.339 4.7e-52
MGI|MGI:24440701064 Nlrc3 "NLR family, CARD domain 0.705 0.395 0.319 1.9e-46
RGD|2321956456 LOC100360501 "ribonuclease inh 0.623 0.815 0.269 2.2e-28
RGD|621398456 Rnh1 "ribonuclease/angiogenin 0.634 0.831 0.264 3.6e-28
MGI|MGI:1195456456 Rnh1 "ribonuclease/angiogenin 0.604 0.791 0.266 1e-26
UNIPROTKB|P10775456 RNH1 "Ribonuclease inhibitor" 0.644 0.844 0.263 1e-26
UNIPROTKB|P13489461 RNH1 "Ribonuclease inhibitor" 0.664 0.861 0.258 7.5e-26
RGD|1562269953 Nod1 "nucleotide-binding oligo 0.376 0.236 0.330 1.4e-24
ZFIN|ZDB-GENE-110913-19 1252 si:dkey-156k2.3 "si:dkey-156k2 0.649 0.309 0.257 3.7e-24
TAIR|locus:2194604 emb2004 "embryo defective 2004" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 1979 (701.7 bits), Expect = 1.4e-204, P = 1.4e-204
 Identities = 403/603 (66%), Positives = 464/603 (76%)

Query:     3 STSTISLYSHPKLSHRAQPVLSRSFCQARDAPLS----FALPFSGTRRCFRLKRLVVKAA 58
             STS+++L+S PK S       S    +   + +S    F  P     R  RL    +KAA
Sbjct:     5 STSSLNLHSLPKASSGLGQWKSGFRYELLGSSVSRNRLFVSPVVIHHRSPRLP--AIKAA 62

Query:    59 ARPEGGXXXXXXXXXXXXDNALTTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPS 118
                +GG             +    A V+QIAS V+P G F   TFVLWK+V K + PK  
Sbjct:    63 YNSDGGSKRSRVYKESQAASGFPNAKVQQIASSVLPLGSFAVVTFVLWKVVGKFMSPKSP 122

Query:   119 RPS----KPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNF 174
             + S      + +G+ WS+GAGTNLL GF  K+ RE+KQ LNEFAKELR+F SVDMSG NF
Sbjct:   123 KTSAGENNSSTQGVKWSIGAGTNLLQGFAAKVDREAKQRLNEFAKELRSFRSVDMSGCNF 182

Query:   175 GDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEG 234
             GDEGLFFLAESLGYNQT EEVSF+ANGITAAG+KAFDGVLQSNI LK LNLSGNPIGDEG
Sbjct:   183 GDEGLFFLAESLGYNQTVEEVSFSANGITAAGVKAFDGVLQSNIMLKILNLSGNPIGDEG 242

Query:   235 VKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSL 294
              K LC  L++N+ +E LQL+S D+ DEGAK IAELLK NS LR++ELNNNMIDYSGFTSL
Sbjct:   243 AKTLCATLMENSSIEILQLNSTDIGDEGAKEIAELLKRNSTLRIIELNNNMIDYSGFTSL 302

Query:   295 AEALLENSTIRSLHXXXXXXXXXXXXXXXXXXXXXKSLRELHLHGNSIGDEGIRALMSGL 354
             A ALLEN+TIR+LH                     KSLRELHLHGNSIGDEG RALM+GL
Sbjct:   303 AGALLENNTIRNLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGTRALMAGL 362

Query:   355 SSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQN 414
             SS KGK+A+LD+GNNSISAKGAF+VAEYIK  KSL+W+NLYMNDIGDEGAEKIAD+LKQN
Sbjct:   363 SSHKGKVALLDLGNNSISAKGAFYVAEYIKRSKSLVWLNLYMNDIGDEGAEKIADSLKQN 422

Query:   415 RTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNIN 474
             R+I TIDLGGNNIH++G +AIA+ LKDN++IT+L++ YNPIG DGAKALSE+LKFHGN+ 
Sbjct:   423 RSIATIDLGGNNIHAEGVNAIAQALKDNAIITTLEVGYNPIGPDGAKALSEILKFHGNVK 482

Query:   475 TLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSID 534
             TLKLGWCQI A GAE VADMLRYNNTIS+LDLRANGLRDEGA CLA+S KVVNEALTS+D
Sbjct:   483 TLKLGWCQIAAKGAEHVADMLRYNNTISVLDLRANGLRDEGASCLARSLKVVNEALTSVD 542

Query:   535 LAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVN 594
             L FNEIRDDGAFAIAQALKANEDV VTS+NL NNF+TKFGQSALTDA+D V EM+EKEV 
Sbjct:   543 LGFNEIRDDGAFAIAQALKANEDVTVTSINLGNNFITKFGQSALTDARDHVLEMTEKEVE 602

Query:   595 IFF 597
             IFF
Sbjct:   603 IFF 605




GO:0005739 "mitochondrion" evidence=ISM;IDA
GO:0009793 "embryo development ending in seed dormancy" evidence=NAS
GO:0009941 "chloroplast envelope" evidence=IDA
GO:0009536 "plastid" evidence=IDA
GO:0009507 "chloroplast" evidence=IDA
UNIPROTKB|Q7RTR2 NLRC3 "Protein NLRC3" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
MGI|MGI:2444070 Nlrc3 "NLR family, CARD domain containing 3" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
RGD|2321956 LOC100360501 "ribonuclease inhibitor-like" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
RGD|621398 Rnh1 "ribonuclease/angiogenin inhibitor 1" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
MGI|MGI:1195456 Rnh1 "ribonuclease/angiogenin inhibitor 1" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
UNIPROTKB|P10775 RNH1 "Ribonuclease inhibitor" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|P13489 RNH1 "Ribonuclease inhibitor" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
RGD|1562269 Nod1 "nucleotide-binding oligomerization domain containing 1" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-110913-19 si:dkey-156k2.3 "si:dkey-156k2.3" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Fail to connect to STRING server


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query597
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 3e-37
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 2e-35
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 1e-30
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 1e-27
COG5238388 COG5238, RNA1, Ran GTPase-activating protein (RanG 4e-08
COG5238388 COG5238, RNA1, Ran GTPase-activating protein (RanG 3e-07
COG5238388 COG5238, RNA1, Ran GTPase-activating protein (RanG 9e-06
COG5238 388 COG5238, RNA1, Ran GTPase-activating protein (RanG 2e-04
smart0036828 smart00368, LRR_RI, Leucine rich repeat, ribonucle 4e-04
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
 Score =  140 bits (355), Expect = 3e-37
 Identities = 85/291 (29%), Positives = 133/291 (45%), Gaps = 32/291 (10%)

Query: 156 EFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAA---------------- 199
           E   +L     + + G   G+E    LA +L    + +E+  +                 
Sbjct: 17  ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQG 76

Query: 200 --------------NGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDN 245
                         N +   G    + +L+S+ +L+ L L+ N +GD G++ L   L D 
Sbjct: 77  LTKGCGLQELDLSDNALGPDGCGVLESLLRSS-SLQELKLNNNGLGDRGLRLLAKGLKDL 135

Query: 246 A-GVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTI 304
              +E+L L    L     +A+A+ L+ N  L+ L L NN I  +G  +LAE L  N  +
Sbjct: 136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNL 195

Query: 305 RSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVL 364
             L LN N     GA+ALA+ L   KSL  L+L  N++ D G  AL S L S    L  L
Sbjct: 196 EVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL 255

Query: 365 DIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNR 415
            +  N I+  GA  +AE +   +SLL ++L  N  G+EGA+ +A++L +  
Sbjct: 256 SLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPG 306


LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>gnl|CDD|197686 smart00368, LRR_RI, Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 597
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.97
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.97
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.97
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.95
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.95
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.95
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 99.95
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 99.95
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.93
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.91
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.88
KOG4308478 consensus LRR-containing protein [Function unknown 99.86
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.8
KOG4308478 consensus LRR-containing protein [Function unknown 99.8
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.76
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 99.75
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.75
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 99.71
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 99.66
KOG4341483 consensus F-box protein containing LRR [General fu 99.66
KOG4341483 consensus F-box protein containing LRR [General fu 99.65
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 99.65
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.61
KOG4237498 consensus Extracellular matrix protein slit, conta 99.59
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 99.58
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 99.57
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.55
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 99.5
KOG4237 498 consensus Extracellular matrix protein slit, conta 99.49
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 99.39
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 99.38
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 99.32
KOG0617264 consensus Ras suppressor protein (contains leucine 99.22
KOG0617264 consensus Ras suppressor protein (contains leucine 99.12
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 98.98
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.92
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 98.91
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.91
KOG1947482 consensus Leucine rich repeat proteins, some prote 98.75
KOG1947482 consensus Leucine rich repeat proteins, some prote 98.65
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.61
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 98.61
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.61
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 98.6
KOG2982418 consensus Uncharacterized conserved protein [Funct 98.57
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 98.54
KOG2982418 consensus Uncharacterized conserved protein [Funct 98.52
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 98.49
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 98.38
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 98.33
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 98.3
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 98.25
PLN03150623 hypothetical protein; Provisional 98.0
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 97.9
PLN03150623 hypothetical protein; Provisional 97.86
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 97.82
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 97.81
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 97.79
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 97.74
KOG4242553 consensus Predicted myosin-I-binding protein [Cell 97.69
KOG2123388 consensus Uncharacterized conserved protein [Funct 97.58
KOG4242553 consensus Predicted myosin-I-binding protein [Cell 97.54
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 97.5
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 97.48
KOG2123388 consensus Uncharacterized conserved protein [Funct 97.43
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.41
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.36
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 97.25
KOG3735353 consensus Tropomodulin and leiomodulin [Cytoskelet 97.03
KOG3864221 consensus Uncharacterized conserved protein [Funct 97.02
KOG3864221 consensus Uncharacterized conserved protein [Funct 96.93
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 96.38
smart0036828 LRR_RI Leucine rich repeat, ribonuclease inhibitor 96.3
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 96.24
KOG3735353 consensus Tropomodulin and leiomodulin [Cytoskelet 96.08
smart0036828 LRR_RI Leucine rich repeat, ribonuclease inhibitor 95.99
PRK15386426 type III secretion protein GogB; Provisional 95.93
PF1351624 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI 95.85
PRK15386426 type III secretion protein GogB; Provisional 95.69
PF1351624 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI 95.64
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 93.65
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 92.32
KOG3763585 consensus mRNA export factor TAP/MEX67 [RNA proces 86.51
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 85.47
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 84.83
KOG3763585 consensus mRNA export factor TAP/MEX67 [RNA proces 81.04
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
Probab=99.97  E-value=4e-28  Score=246.00  Aligned_cols=315  Identities=31%  Similarity=0.400  Sum_probs=216.6

Q ss_pred             EEEccCCCCChhHHHHHHHHHhcCCCcCEEEecCCCCChHHHHHHHHHHHcCCCccEEEeccCCCC--hhhHHHHHHHHh
Q 007577          222 TLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMID--YSGFTSLAEALL  299 (597)
Q Consensus       222 ~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~--~~~~~~l~~~l~  299 (597)
                      .|+|.++.+++..+..+...   ..+|++|++++|.+++.+...++..+...++|++|+++++.+.  ..++..++..+.
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~---l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~   78 (319)
T cd00116           2 QLSLKGELLKTERATELLPK---LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLT   78 (319)
T ss_pred             ccccccCcccccchHHHHHH---HhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHH
Confidence            45666666664444333332   3557777777777777777777777777777777777777766  455666666666


Q ss_pred             hCCCccEEEcCCCCCChHHHHHHHHHhhcCCCCCEEEccCCCCChHHHHHHHHhhhcCccccceeeccCCCCChhHHHHH
Q 007577          300 ENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHV  379 (597)
Q Consensus       300 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l  379 (597)
                      .+++|+.|++++|.+.......+...... ++|++|++++|.+++.+...+...+....++|+.|++++|.++..+...+
T Consensus        79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~  157 (319)
T cd00116          79 KGCGLQELDLSDNALGPDGCGVLESLLRS-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEAL  157 (319)
T ss_pred             hcCceeEEEccCCCCChhHHHHHHHHhcc-CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHH
Confidence            67777777777777665444444333333 56888888888777666666665554433577888888887776666666


Q ss_pred             HHHHHcCCCCcEEEccCCCCCcHHHHHHHHHHhcCCCccEEEccCCCCChHHHHHHHHHhhcCCCcCEEECcCCCCCHHH
Q 007577          380 AEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADG  459 (597)
Q Consensus       380 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~  459 (597)
                      ...+..+++|++|++++|.+++.++..++..+..+++|++|++++|.+++.+...+...+..+++|++|++++|.+++.+
T Consensus       158 ~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~  237 (319)
T cd00116         158 AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAG  237 (319)
T ss_pred             HHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHH
Confidence            67777777788888888888777777777777777788888888888877777777777777777888888888777766


Q ss_pred             HHHHHHHHh-hCCCcCEEecCCCCCChhHHHHHHHHHhcCCCccEEEccCCCCChHHHHHHHHHHhhcCccccEEEccCC
Q 007577          460 AKALSEVLK-FHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFN  538 (597)
Q Consensus       460 ~~~l~~~l~-~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~i~~~~~~~l~~~l~~~n~~L~~L~Ls~n  538 (597)
                      +..+...+. ..+.|++|++++|.+++.+...+...+..+++|+.+++++|.+++.+...++..+....+.|++||+.+|
T Consensus       238 ~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (319)
T cd00116         238 AAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDD  317 (319)
T ss_pred             HHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCC
Confidence            666655433 2457777777777777666666666666667777777777777777777776666543356777777666


Q ss_pred             CC
Q 007577          539 EI  540 (597)
Q Consensus       539 ~i  540 (597)
                      .+
T Consensus       318 ~~  319 (319)
T cd00116         318 SF  319 (319)
T ss_pred             CC
Confidence            53



LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG4308 consensus LRR-containing protein [Function unknown] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG4308 consensus LRR-containing protein [Function unknown] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG3735 consensus Tropomodulin and leiomodulin [Cytoskeleton] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>KOG3735 consensus Tropomodulin and leiomodulin [Cytoskeleton] Back     alignment and domain information
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification] Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification] Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query597
2bnh_A457 Porcine Ribonuclease Inhibitor Length = 457 2e-26
2bnh_A457 Porcine Ribonuclease Inhibitor Length = 457 3e-24
3tsr_E457 X-Ray Structure Of Mouse Ribonuclease Inhibitor Com 8e-26
1a4y_A460 Ribonuclease Inhibitor-Angiogenin Complex Length = 1e-22
1z7x_W461 X-Ray Structure Of Human Ribonuclease Inhibitor Com 1e-22
3un9_A372 Crystal Structure Of An Immune Receptor Length = 37 8e-06
1yrg_A385 The Crystal Structure Of Rna1p: A New Fold For A Gt 4e-05
1k5d_C386 Crystal Structure Of Ran-Gppnhp-Ranbp1-Rangap Compl 5e-05
>pdb|2BNH|A Chain A, Porcine Ribonuclease Inhibitor Length = 457 Back     alignment and structure

Iteration: 1

Score = 117 bits (292), Expect = 2e-26, Method: Compositional matrix adjust. Identities = 97/374 (25%), Positives = 173/374 (46%), Gaps = 8/374 (2%) Query: 150 SKQTLNEFAKELRA---FSSVDMSGRNFGDEGLFFLAESLGYNQTA-EEVSFAANGITAA 205 +++ + LRA + + + GD G+ + + L +++S +T A Sbjct: 37 TEEHCKDIGSALRANPSLTELCLRTNELGDAGVHLVLQGLQSPTCKIQKLSLQNCSLTEA 96 Query: 206 GIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVD-NAGVERLQLSSVDLRDEGAK 264 G L+S L+ L+LS NP+GD G++ LC+ L+D +E+LQL L + Sbjct: 97 GCGVLPSTLRSLPTLRELHLSDNPLGDAGLRLLCEGLLDPQCHLEKLQLEYCRLTAASCE 156 Query: 265 AIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENST-IRSLHXXXXXXXXXXXXXXX 323 +A +L+ L+ L ++NN I +G L + L +++ + +L Sbjct: 157 PLASVLRATRALKELTVSNNDIGEAGARVLGQGLADSACQLETLRLENCGLTPANCKDLC 216 Query: 324 XXXXXXKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYI 383 SLREL L N +GD GI L GL S +L L + I+A G + + Sbjct: 217 GIVASQASLRELDLGSNGLGDAGIAELCPGLLSPASRLKTLWLWECDITASGCRDLCRVL 276 Query: 384 KNCKSLLWINLYMNDIGDEGAEKIADALKQ-NRTITTIDLGGNNIHSKGASAIARVLKDN 442 + ++L ++L N +GDEGA + ++L Q + ++ + ++ + ++ +L N Sbjct: 277 QAKETLKELSLAGNKLGDEGARLLCESLLQPGCQLESLWVKSCSLTAACCQHVSLMLTQN 336 Query: 443 SVITSLDLAYNPIGADGAKALSEVLKFHG-NINTLKLGWCQIGASGAEFVADMLRYNNTI 501 + L L+ N +G G + L + L G + L LG C++ SG +A +L N ++ Sbjct: 337 KHLLELQLSSNKLGDSGIQELCQALSQPGTTLRVLCLGDCEVTNSGCSSLASLLLANRSL 396 Query: 502 SILDLRANGLRDEG 515 LDL N + D G Sbjct: 397 RELDLSNNCVGDPG 410
>pdb|2BNH|A Chain A, Porcine Ribonuclease Inhibitor Length = 457 Back     alignment and structure
>pdb|3TSR|E Chain E, X-Ray Structure Of Mouse Ribonuclease Inhibitor Complexed With Mouse Ribonuclease 1 Length = 457 Back     alignment and structure
>pdb|1A4Y|A Chain A, Ribonuclease Inhibitor-Angiogenin Complex Length = 460 Back     alignment and structure
>pdb|1Z7X|W Chain W, X-Ray Structure Of Human Ribonuclease Inhibitor Complexed With Ribonuclease I Length = 461 Back     alignment and structure
>pdb|3UN9|A Chain A, Crystal Structure Of An Immune Receptor Length = 372 Back     alignment and structure
>pdb|1YRG|A Chain A, The Crystal Structure Of Rna1p: A New Fold For A Gtpase- Activating Protein Length = 385 Back     alignment and structure
>pdb|1K5D|C Chain C, Crystal Structure Of Ran-Gppnhp-Ranbp1-Rangap Complex Length = 386 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query597
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 1e-126
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 1e-107
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 3e-96
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 1e-91
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 1e-95
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 9e-76
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 5e-72
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 2e-40
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 3e-32
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 8e-85
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 3e-78
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 5e-77
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 4e-71
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 2e-50
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 2e-32
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 4e-74
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 1e-67
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 3e-59
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 4e-33
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 3e-39
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 2e-37
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 4e-37
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 2e-34
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 1e-32
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 3e-30
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 7e-29
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 7e-31
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 1e-29
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 6e-27
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 2e-26
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 7e-24
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 2e-22
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 2e-22
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 1e-13
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 4e-12
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 1e-25
3ogk_B 592 Coronatine-insensitive protein 1; leucine rich rep 3e-20
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 8e-15
3ogk_B 592 Coronatine-insensitive protein 1; leucine rich rep 1e-13
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 2e-22
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 1e-18
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 2e-16
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 4e-13
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 8e-13
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 1e-12
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 4e-10
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 6e-09
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 7e-22
2p1m_B 594 Transport inhibitor response 1 protein; F-BOX, leu 6e-20
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 4e-17
2p1m_B 594 Transport inhibitor response 1 protein; F-BOX, leu 1e-14
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 4e-14
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 1e-20
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 2e-19
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 4e-18
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 3e-11
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 9e-07
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 2e-19
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 3e-14
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 2e-11
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 3e-11
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 3e-04
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 3e-19
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 7e-16
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-15
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-15
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 4e-15
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 4e-10
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 4e-10
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 7e-05
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 6e-19
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-18
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 1e-17
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 2e-16
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-14
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 3e-11
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 1e-05
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 2e-18
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-14
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 5e-14
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 5e-12
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 8e-11
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 9e-18
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 3e-13
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 3e-12
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 4e-11
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 3e-16
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 3e-14
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 2e-10
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 3e-16
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 1e-15
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 1e-13
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 1e-11
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-10
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-10
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-06
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 6e-16
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 2e-15
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 1e-06
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 5e-05
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 9e-16
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 3e-15
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 4e-09
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 2e-04
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 3e-14
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 8e-11
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 1e-07
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 1e-05
4fmz_A347 Internalin; leucine rich repeat, structural genomi 3e-14
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-12
4fmz_A347 Internalin; leucine rich repeat, structural genomi 8e-07
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 6e-14
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 8e-14
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 3e-13
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 4e-04
3o6n_A 390 APL1; leucine-rich repeat, protein binding; HET: N 6e-14
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 7e-14
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 2e-13
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 3e-11
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 4e-04
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 3e-13
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 7e-09
1o6v_A466 Internalin A; bacterial infection, extracellular r 7e-12
1o6v_A 466 Internalin A; bacterial infection, extracellular r 9e-10
4ezg_A197 Putative uncharacterized protein; internalin-A, le 9e-12
4ezg_A197 Putative uncharacterized protein; internalin-A, le 2e-08
4ezg_A197 Putative uncharacterized protein; internalin-A, le 7e-07
4ezg_A197 Putative uncharacterized protein; internalin-A, le 8e-04
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 1e-11
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 5e-10
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 5e-04
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 1e-11
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 1e-11
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 7e-11
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 3e-07
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 1e-11
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 2e-10
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 3e-08
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 1e-06
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 8e-04
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 1e-11
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 2e-10
3v47_A 455 TOLL-like receptor 5B and variable lymphocyte REC 1e-08
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 3e-07
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 2e-11
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 1e-09
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 3e-06
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 7e-05
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 4e-11
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 3e-09
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 1e-08
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-10
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 5e-10
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 4e-09
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 8e-07
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 6e-10
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 1e-05
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 2e-05
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 7e-10
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 3e-06
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 2e-04
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 1e-09
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 2e-09
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 1e-07
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 1e-09
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 1e-07
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 5e-06
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 1e-05
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 3e-05
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 2e-09
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 5e-09
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 1e-07
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 2e-07
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 3e-09
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 8e-09
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 2e-04
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 1e-08
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 6e-06
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 1e-08
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 4e-08
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 3e-06
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 5e-05
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 6e-08
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 2e-06
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 9e-08
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 4e-06
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 1e-07
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 2e-06
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 2e-04
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 1e-07
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 4e-06
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 2e-07
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 8e-05
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 1e-04
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 6e-04
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 3e-07
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 5e-05
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 9e-07
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 1e-06
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 8e-04
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 1e-06
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 3e-04
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 1e-06
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 2e-04
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 5e-06
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 1e-05
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 1e-04
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 2e-04
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 6e-04
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 2e-04
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 3e-04
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 4e-04
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 8e-04
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 4e-04
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
 Score =  378 bits (973), Expect = e-126
 Identities = 109/420 (25%), Positives = 180/420 (42%), Gaps = 9/420 (2%)

Query: 166 SVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNL 225
           S+D+      D      AE L   Q  + V     G+T A  K     L+ N AL  LNL
Sbjct: 7   SLDIQCEELSDARW---AELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 226 SGNPIGDEGVKCLCDIL-VDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNN 284
             N +GD GV C+   L   +  +++L L +  L   G   ++  L+    L+ L L++N
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 285 MIDYSGFTSLAEALLE-NSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIG 343
           ++  +G   L E LL+    +  L L      A     LA  L      +EL +  N I 
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

Query: 344 DEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEG 403
           + G+R L  GL     +L  L + +  +++     +   + +  SL  + L  N +GD G
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243

Query: 404 AEKIADALKQ-NRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKA 462
             ++   L   +  + T+ +    I +KG   + RVL+    +  L LA N +G +GA+ 
Sbjct: 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303

Query: 463 LSEVLKF-HGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQ 521
           L E L      + +L +  C   A+     + +L  N  +  L +  N L D G + L Q
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363

Query: 522 SFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDA 581
                   L  + LA  ++ D    ++A  L AN   ++  L+L+NN L   G   L ++
Sbjct: 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH--SLRELDLSNNCLGDAGILQLVES 421


>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query597
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 100.0
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 100.0
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 100.0
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 100.0
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.98
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.98
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.97
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.97
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.97
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.96
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.95
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.95
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.95
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 99.95
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 99.95
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 99.94
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.94
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.94
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.94
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.94
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 99.94
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.94
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.94
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.94
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.94
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.94
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.94
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.93
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.93
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.93
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.93
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.93
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 99.92
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.92
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 99.92
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.92
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.91
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.91
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.91
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.91
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.91
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.91
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.9
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.9
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.89
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.89
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.89
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.88
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.87
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.87
4g8a_A 635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.86
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.86
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.86
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.86
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.85
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.85
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.84
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.84
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.82
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.81
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.81
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.81
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.81
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.8
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.8
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.8
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.77
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.77
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.77
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.76
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 99.76
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.76
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.76
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.76
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 99.76
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.75
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.74
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.73
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.73
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.73
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.73
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.73
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.73
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.72
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.71
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.7
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 99.68
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 99.66
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.65
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.64
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.64
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.63
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.63
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.62
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.6
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.59
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.56
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.55
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.53
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.52
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.49
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.48
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.48
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.48
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.48
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.47
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.45
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.44
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.43
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 99.42
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.41
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 99.41
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.4
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.29
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.28
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.28
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.25
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 99.24
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.24
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.22
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.22
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.22
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.2
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.2
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 99.2
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.2
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.2
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.19
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.18
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.18
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.17
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.16
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.13
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.11
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.08
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 99.07
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.02
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.96
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.91
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.89
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.87
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.86
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.86
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.84
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 98.78
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 98.74
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.57
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.54
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.45
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.41
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.21
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.18
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 98.18
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 98.01
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 97.98
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 97.88
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 97.82
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.8
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.31
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.14
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 81.22
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 80.52
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
Probab=100.00  E-value=3.5e-45  Score=389.14  Aligned_cols=413  Identities=26%  Similarity=0.379  Sum_probs=206.2

Q ss_pred             CCcEEEcCCCCCCHHHHHHHHHHhccCCCccEEEeccCCCCHHHHHHHHHHhhhCCCccEEEccCCCCChhHHHHHHHHH
Q 007577          163 AFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDIL  242 (597)
Q Consensus       163 ~L~~L~Ls~~~l~~~~~~~l~~~l~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l  242 (597)
                      ++++|+|+++.+++..+..+   +..+++|++|++++|.+++.+...++..+..+++|++|++++|.+++.+...+...+
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~---~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l   80 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAEL---LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGL   80 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHH---HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred             cceehhhhhcccCchhHHHH---HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHH
Confidence            34555555555554442221   222345555555555555555555555555555555555555555544444444332


Q ss_pred             hcCC-CcCEEEecCCCCChHHHHHHHHHHHcCCCccEEEeccCCCChhhHHHHHHHHhh-CCCccEEEcCCCCCChHHHH
Q 007577          243 VDNA-GVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLE-NSTIRSLHLNGNYGGALGAN  320 (597)
Q Consensus       243 ~~~~-~L~~L~Ls~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~-~~~L~~L~L~~n~i~~~~~~  320 (597)
                      .... +|++|++++|.+++.++..++..+..+++|++|++++|.+++.+...+...+.. .++|++|++++|.++..+..
T Consensus        81 ~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~  160 (461)
T 1z7x_W           81 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE  160 (461)
T ss_dssp             CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred             hhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH
Confidence            2211 455555555555555444555555555555555555555554444444444332 33455555555555555444


Q ss_pred             HHHHHhhcCCCCCEEEccCCCCChHHHHHHHHhhhcCccccceeeccCCCCChhHHHHHHHHHHcCCCCcEEEccCCCCC
Q 007577          321 ALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIG  400 (597)
Q Consensus       321 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~  400 (597)
                      .++..+..+++|++|++++|.+++.+...+...+....++|+.|++++|.+++.+...++..+..+++|++|++++|.++
T Consensus       161 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~  240 (461)
T 1z7x_W          161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG  240 (461)
T ss_dssp             HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred             HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence            44455555555555555555555554444444444334455555555555555544445555555555555555555555


Q ss_pred             cHHHHHHHHHHh-cCCCccEEEccCCCCChHHHHHHHHHhhcCCCcCEEECcCCCCCHHHHHHHHHHHhhC-CCcCEEec
Q 007577          401 DEGAEKIADALK-QNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFH-GNINTLKL  478 (597)
Q Consensus       401 ~~~~~~l~~~l~-~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~-~~L~~L~L  478 (597)
                      +.++..+...+. .+++|++|++++|.+++.+...++..+..+++|++|++++|.+++.++..+...+... ++|++|++
T Consensus       241 ~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L  320 (461)
T 1z7x_W          241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV  320 (461)
T ss_dssp             HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred             hHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEc
Confidence            554444444433 2445555555555555555555555555555555555555555555544444444322 35555555


Q ss_pred             CCCCCChhHHHHHHHHHhcCCCccEEEccCCCCChHHHHHHHHHHhhcCccccEEEccCCCCChHHHHHHHHHHHhCCCC
Q 007577          479 GWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDV  558 (597)
Q Consensus       479 ~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~i~~~~~~~l~~~l~~~n~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~  558 (597)
                      ++|.+++.+...+...+..+++|++|++++|.+++.++..+.+.+...+++|++|++++|.+++.+...+...+..++. 
T Consensus       321 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~-  399 (461)
T 1z7x_W          321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS-  399 (461)
T ss_dssp             TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCC-
T ss_pred             CCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCC-
Confidence            5555555554455555555555555555555555555555554443323445555555555555555555544444443 


Q ss_pred             ceeEEEcccCccchhhHHHHHH
Q 007577          559 AVTSLNLANNFLTKFGQSALTD  580 (597)
Q Consensus       559 ~L~~L~L~~N~i~~~~~~~l~~  580 (597)
                       |++|+|++|.|++.+...+.+
T Consensus       400 -L~~L~l~~N~i~~~~~~~l~~  420 (461)
T 1z7x_W          400 -LRELDLSNNCLGDAGILQLVE  420 (461)
T ss_dssp             -CCEEECCSSSCCHHHHHHHHH
T ss_pred             -ccEEECCCCCCCHHHHHHHHH
Confidence             555555555555555544443



>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 597
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 1e-23
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 9e-21
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 1e-18
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 1e-18
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 4e-18
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 2e-17
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 4e-17
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 5e-17
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 1e-16
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 1e-16
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 4e-16
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 7e-16
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 2e-15
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 3e-15
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 6e-15
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 6e-13
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 3e-12
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 6e-11
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 4e-04
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.002
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 1e-20
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 5e-20
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 1e-19
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 6e-19
d2ca6a1 344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 7e-10
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 4e-14
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 2e-13
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 2e-13
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 4e-12
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 2e-09
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 3e-06
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 3e-12
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 4e-12
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 2e-09
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 7e-09
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 2e-08
d2astb2284 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 2e-05
d2astb2 284 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 0.004
d1xkua_305 c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 3e-05
d1xkua_305 c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 0.001
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 0.001
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 0.002
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]
 Score =  101 bits (252), Expect = 1e-23
 Identities = 108/420 (25%), Positives = 173/420 (41%), Gaps = 9/420 (2%)

Query: 166 SVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNL 225
           S+D+      D     L   L   Q    V     G+T A  K     L+ N AL  LNL
Sbjct: 6   SLDIQCEELSDARWAELLPLLQQCQV---VRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 226 SGNPIGDEGVKCLCDIL-VDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNN 284
             N +GD GV C+   L   +  +++L L +  L   G   ++  L+    L+ L L++N
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122

Query: 285 MIDYSGFTSLAEALLENSTI-RSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIG 343
           ++  +G   L E LL+       L L      A     LA  L      +EL +  N I 
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182

Query: 344 DEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEG 403
           + G+R L  GL     +L  L + +  +++     +   + +  SL  + L  N +GD G
Sbjct: 183 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242

Query: 404 AE-KIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKA 462
                   L  +  + T+ +    I +KG   + RVL+    +  L LA N +G +GA+ 
Sbjct: 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302

Query: 463 LSEVLKFHGNINTL-KLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQ 521
           L E L   G       +  C   A+     + +L  N  +  L +  N L D G + L Q
Sbjct: 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362

Query: 522 SFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDA 581
                   L  + LA  ++ D    ++A  L AN   ++  L+L+NN L   G   L ++
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH--SLRELDLSNNCLGDAGILQLVES 420


>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query597
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 100.0
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 100.0
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.97
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.96
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.85
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.84
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.82
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.79
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.64
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.62
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.57
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.57
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 99.57
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.55
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 99.55
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.53
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 99.52
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 99.51
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.51
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.51
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.51
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.47
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.46
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.43
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.43
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.4
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.33
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.19
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.13
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.09
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.08
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.03
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.99
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.96
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.95
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.88
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 98.73
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 98.7
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.32
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.29
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.21
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.12
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00  E-value=2.8e-37  Score=324.69  Aligned_cols=429  Identities=19%  Similarity=0.266  Sum_probs=261.1

Q ss_pred             HHHHHHHHhcCCCcEEEcCCCCCCHHHHHHHHHHhccCCCccEEEeccCCCCHHHHHHHHHHhhh-CCCccEEEccCCCC
Q 007577          152 QTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQS-NIALKTLNLSGNPI  230 (597)
Q Consensus       152 ~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~l~~~l~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~-~~~L~~L~Ls~n~l  230 (597)
                      ..+.+++..+++++.|+|++|.+++.++..|+..+..+++|++|+|++|.|++.++..+...+.. ..+|++|+|++|.+
T Consensus        17 ~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i   96 (460)
T d1z7xw1          17 ARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL   96 (460)
T ss_dssp             HHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCC
T ss_pred             HHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCc
Confidence            33344444455555555555555555555555555555555555555555555555555544432 22455555555555


Q ss_pred             ChhHHHHHHHHHhcCCCcCEEEecCCCCChHHHHHHHHHHHcC-CCccEEEeccCCCChhhHHHHHHHHhhCCCccEEEc
Q 007577          231 GDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNN-SILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHL  309 (597)
Q Consensus       231 ~~~~~~~l~~~l~~~~~L~~L~Ls~~~l~~~~~~~l~~~l~~~-~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~L  309 (597)
                      ++.+...++..+..+++|++|++++|.+++.++..+...+... ............+...+...+...+.....++.+.+
T Consensus        97 t~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l  176 (460)
T d1z7xw1          97 TGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTV  176 (460)
T ss_dssp             BGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEEC
T ss_pred             cccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccccccccccccccccc
Confidence            5555555555555555555555555555555555554444322 123334444444444445555555555666666666


Q ss_pred             CCCCCChHHHHHHHHHhhcC-CCCCEEEccCCCCChHHHHHHHHhhhcCccccceeeccCCCCChhHHHHH-HHHHHcCC
Q 007577          310 NGNYGGALGANALAKGLEGN-KSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHV-AEYIKNCK  387 (597)
Q Consensus       310 ~~n~i~~~~~~~l~~~l~~~-~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l-~~~l~~~~  387 (597)
                      +++.+.+.+...+...+... .....+++..+.+...+.......+.. .+.++.+++++|.+.+.+.... ........
T Consensus       177 s~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~-~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~  255 (460)
T d1z7xw1         177 SNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS-KASLRELALGSNKLGDVGMAELCPGLLHPSS  255 (460)
T ss_dssp             CSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHH-CTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhcccccccc-cccccccchhhccccccccchhhcccccccc
Confidence            66666555544444444332 245566666666655555444444432 2356777777776665543322 22333456


Q ss_pred             CCcEEEccCCCCCcHHHHHHHHHHhcCCCccEEEccCCCCChHHHHHHHHHhhcC-CCcCEEECcCCCCCHHHHHHHHHH
Q 007577          388 SLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDN-SVITSLDLAYNPIGADGAKALSEV  466 (597)
Q Consensus       388 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~-~~L~~L~Ls~n~i~~~~~~~l~~~  466 (597)
                      .++.|++++|.+.......+...+..++.++.+++++|.+++.+...++..+... ..|+.+++++|.+++.++..+...
T Consensus       256 ~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~  335 (460)
T d1z7xw1         256 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV  335 (460)
T ss_dssp             CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccc
Confidence            6777777777777776666666676777777777777777777777776665543 567777777777777777777777


Q ss_pred             HhhCCCcCEEecCCCCCChhHHHHHHHHHh-cCCCccEEEccCCCCChHHHHHHHHHHhhcCccccEEEccCCCCChHHH
Q 007577          467 LKFHGNINTLKLGWCQIGASGAEFVADMLR-YNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGA  545 (597)
Q Consensus       467 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~-~~~~L~~L~l~~n~i~~~~~~~l~~~l~~~n~~L~~L~Ls~n~i~~~~~  545 (597)
                      +..+++|++|+|++|+|++.+...++..+. .++.|++|++++|.|++.++..+++.+.. +++|++|||++|.|++.|.
T Consensus       336 ~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~-~~~L~~L~Ls~N~i~~~g~  414 (460)
T d1z7xw1         336 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA-NHSLRELDLSNNCLGDAGI  414 (460)
T ss_dssp             HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHH-CCCCCEEECCSSSCCHHHH
T ss_pred             cccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhc-CCCCCEEECCCCcCCHHHH
Confidence            777777777777777777777777766664 35667777777777777777777766653 3677777777777777777


Q ss_pred             HHHHHHHHhCCCCceeEEEcccCccchhhHHHHHHHHH
Q 007577          546 FAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKD  583 (597)
Q Consensus       546 ~~l~~~l~~~~~~~L~~L~L~~N~i~~~~~~~l~~~~~  583 (597)
                      ..+.+.++.+. +.|+.|++.+|.+.+...+.+.....
T Consensus       415 ~~l~~~l~~~~-~~L~~l~l~~~~~~~~~~~~l~~l~~  451 (460)
T d1z7xw1         415 LQLVESVRQPG-CLLEQLVLYDIYWSEEMEDRLQALEK  451 (460)
T ss_dssp             HHHHHHHTSTT-CCCCEEECTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCC-CccCEEECCCCCCCHHHHHHHHHHHH
Confidence            77777765444 35777777777777766666655443



>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure